Manulife HK and Macau, subsidiaries under MANULIFE-S (00945.HK) +2.000 (+0.664%) Short selling $30.48K; Ratio 1.333% , announced double-digit growth in their 2025 full-year core earnings, annualized premium equivalent (APE) sales, new business value (NBV), and new business contractual service margin (new business CSM).
AASTOCKS Financial News